News
AI · Data Privacy · Healthcare Data · Regulation
AI innovation in healthcare, while enhancing medical imaging and drug discovery, creates significant national security, cybersecurity, and privacy concerns due to its reliance on data, prompting the US government to implement stricter oversight of cross-border health data flows.
Health data, once primarily a HIPAA compliance issue, is now deemed "strategic infrastructure" by governments, crucial for advanced AI systems in medical imaging, patient histories, and genomics. The U.S. Government Accountability Office identifies privacy gaps in federal AI guidelines, noting HIPAA's inadequacy for modern cross-border cloud and AI training environments.
Initiatives like the Protecting Americans’ Data from Foreign Adversaries Act and the Department of Justice’s Data Security Program reflect this shift, as highlighted by Justin Sherman. This new regulatory landscape demands immediate attention from healthcare organizations, including hospitals, insurers, and AI developers, for data mapping, consent management, vendor oversight, and cross-border transfer compliance.
